Want to join the conversation?
$ZBRA said it expects 2Q16 adj. net sales in a range of down 3% to flat from a year ago. Non-GAAP earnings are expected to be in the range of $1.00 to $1.20 per share. For FY16, the company forecast adj.net sales in a range of down 3% to up 1% compared to FY15. $ZBRA said it expects to pay down $300MM of debt principal in 2016.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?